PH
Therapeutic Areas
Firalis Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Cardiovascular Biomarkers R&D | Cardiovascular Diseases | Development |
| Neurodegenerative Biomarkers R&D | Neurodegenerative Diseases | Development |
| Drug-Induced Organ Injury Biomarkers | Kidney, Liver, Vascular Toxicity | Development |
| Inflammatory Disorder Biomarkers (e.g., RA, Vasculitis) | Rheumatoid Arthritis, Autoimmune Vasculitis | Development |